Syon Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Sell
26,550
-2,544
-9% -$227K 0.11% 132
2025
Q4
$2.3M Buy
29,094
+18,015
+163% +$1.41M 0.11% 135
2025
Q3
$886K Sell
11,079
-3,692
-25% -$315K 0.05% 299
2025
Q2
$1.34M Buy
14,771
+4,231
+40% +$386K 0.09% 162
2025
Q1
$988K Buy
10,540
+2,650
+34% +$237K 0.08% 190
2024
Q4
$717K Sell
7,890
-646
-8% -$61.6K 0.06% 207
2024
Q3
$886K Buy
8,536
+322
+4% +$32.8K 0.08% 181
2024
Q2
$797K Buy
8,214
+140
+2% +$12.9K 0.07% 188
2024
Q1
$727K Sell
8,074
-6,714
-45% -$569K 0.07% 208
2023
Q4
$1.18M Buy
14,788
+10,895
+280% +$819K 0.05% 230
2023
Q3
$277K Buy
+3,893
New +$291K 0.03% 288

Other funds holding CL

Syon Capital's CL Position: Q1 2026 in Review

Syon Capital reduced its Colgate-Palmolive (CL) stake by 8.7% in Q1 2026, selling an estimated $227K and leaving 26,550 shares worth $2.26M. The position accounts for 0.11% of the portfolio, ranked #132.

Syon Capital first reported a position in CL in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.3M in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Syon Capital held 26,550 shares of Colgate-Palmolive worth $2.26M as of Q1 2026.
  • Syon Capital sold 2,544 Colgate-Palmolive shares in Q1 2026, an estimated $227K.
  • Colgate-Palmolive made up 0.11% of Syon Capital's portfolio in Q1 2026, its #132 holding.
  • Syon Capital first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's Colgate-Palmolive position peaked at $2.3M in Q4 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.